ORDER A TEST Log In Contact Us

TEMPUS CLINICAL RESEARCH

Tempus TIME powers smart sites creating a network designed to support and accelerate clinical development

Experience faster trial activation, accurate patient matching, enhanced resource utilization, and the power of a unified approach to advance your research goals and bring innovative treatments to patients sooner.

Schedule a demo

Smarter trials, delivered faster.

  • Activate Trials Faster
    Activate Trials Faster

    Tempus TIME’s Just-in-Time model is designed to support efficient site activation in as little as a few days, with onboarding typically completed in 10 weeks or less. Intuitive, automated tools that reduce manual workload and empower researchers to do more.

  • Identify the right patients
    Identify the right patients

    Harness our advanced trial matching services–combining AI, machine learning, and clinical insight–with a clinical team of experts pre-screening the matched patients and presenting potentially eligible patients with a white-glove service to each site.

  • Support financial stability and growth
    Support financial stability and growth

    Activate more trials and access cost savings with the JIT model, save time with automated pre-screening to identify patients, and leverage data-driven trial selection best suited for your site and patient population.

The Tempus TIME program has been instrumental for us in designing and maintaining our clinical research portfolio.  The rapid startup is a truly revolutionary feature.  In addition, there are multiple aspects of the program that make it as easy as possible to identify patients, maximize enrollment, and minimize busy work on our end.

Bert O'Neil, MD, Medical Director, Oncology Clinical Trials, Community Health Network

one of The largest oncology networks in the nation

  • 100 sites representing 800+ clinical locations
  • 1.5k+ clinical trials have been active
  • 2k+ patients consented into our trials
image description

Accelerate study activation and enrollment

On average, TIME completes trial onboarding in 10 weeks or less before activating sites in as little as a few days with our Just-in-Time site activation model.

Through TIME Precision Network and a dedicated group of investigators, Tempus supports Phase I clinical trials by providing rapid site activation and patient enrollment across the US.

Learn more
image description

Enhanced patient pre-screening and matching

Identify potential trial patients, streamline workflows, and accelerate enrollment on one AI-powered platform. Our AI analyzes structured and unstructured clinical data to improve patient identification for trials.

Explore Link
  • Clinical selection tooling: Use patient population data to asses your site’s potential for successful trial enrollment.
  • Pre-screen patients: Quickly pre-screen lists of patients identified as potentially eligible for a specific trial
  • Trial Matching: Nurses review AI-identified matches to confirm eligibility before sharing with TIME network sites.
image description

Learn how others are working with Tempus

  • image description

    TriHealth achieved 64% annual increase in patients enrolled in clinical trials, with Tempus TIME driving 95% of growth.

    Discover how TriHealth leveraged TIME to achieve increased ROI, improve overall study quality, and dramatically increase clinical trial enrollment across their oncology portfolio.

    LEARN MORE
  • image description

    Advancing precision medicine in the community setting with TIME and Next at Cancer and Blood Specialty Clinic

    Discover how Cancer and Blood Specialty Clinic, a community oncology network, utilized Tempus TIME to expedite clinical trial enrollment and is expanding their impact on patient care with Tempus Next, an AI-enabled care pathway platform.

    LEARN MORE
  • image description

    Closing the biomarker testing gap for early stage NSCLC patients at 
a TIME site

    Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio, a TIME Site, to surface and close gaps in biomarker testing for NSCLC patients. 

    LEARN MORE

Featured News and Publications

view all news
  • UPCOMING WEBINAR:

    Oral presentation at ASCO: A technology-enabled clinical trial program’s impact on patient screening and trial enrollment in 2024.

    Tempus’ technology-enabled clinical trial program, utilizing an algorithmic screening platform, was shown to improve patient access and trial enrollment success by centralizing patient data and rapidly matching them to suitable trials.

    Learn more
  • UPCOMING WEBINAR:

    Tempus TIME network expands support of phase I clinical trials to accelerate activation and enrollment

    The TIME Precision Network is a newly formed group of investigators across TIME’s provider site network dedicated to supporting phase I trials.

    Learn more
  • UPCOMING WEBINAR:

    Tempus announces partnership with OneOncology

    Tempus is collaborating with OneOncology, the fastest-growing national platform for independent oncology practices, to broaden patient access to cutting-edge clinical trials.

    Learn more
  • UPCOMING WEBINAR:

    Optimizing clinical trial subject selection: Insights from Exigent Research Network and the Tempus AI TIME program collaboration

    The Exigent Research Network comprises independent community oncology practices engaged in clinical research. This publication describes the Exigent and TIME Program collaboration during a 2-year period and its impact on screening, matching, and enrollment into clinical trials.

    Learn more
  • UPCOMING WEBINAR:

    TriHealth Cancer Institute’s collaboration with the Tempus AI TIME program impact on clinical trial operations and enrollment

    TriHealth Cancer Institute has the largest personalized medicine program serving Cincinnati. TriHealth’s EMR integration with Tempus AI TIME allows for patient screening using an AI powered software TApp that matches to a broad clinical trial portfolio.

    Learn more

Learn more about our clinical research solutions.